About

Alphalab is a Russian innovative company that develops and produces high‑quality PCR test systems for laboratory diagnostics. Founded in 2012 in St. Petersburg on the basis of the clinical research laboratory Explana, the company strives to combine advanced molecular biology technologies with the practical needs of doctors. Focusing on innovation and reliability, Alphalab provides accurate and affordable solutions for laboratory diagnostics in Russia and abroad.

What we do

Alphalab is a leading Russian developer and manufacturer of PCR test systems for diagnostics of infectious and parasitic diseases. We specialize in molecular diagnostics, providing doctors and laboratories with advanced tools for detection of:

  • Helminthiasis and protozoan invasions
  • Intestinal infections
  • Urogenital infections

Our main clients are medical laboratories, clinical diagnostic centers and medical institutions, veterinary laboratories that need accurate, reliable and affordable diagnostic tools.

Our clients choose Alphalab because we offer not just test systems, but comprehensive solutions for effective diagnostics and disease control, contributing to the improvement of the quality of medical services.

Our key advantages

  • Precision and innovation

    The products are developed on the basis of advanced molecular genetic technologies, ensuring high sensitivity and specificity of analyses.

  • High quality standards

    Our products are certified according to GOST ISO 13485-2017 (ISO 13485:2016), meeting international safety requirements.

  • Focus on the needs of medical professionals

    We develop solutions that are truly in demand by medical professionals, helping to improve disease diagnostics.

  • Own production

    Our modern production facilities meet all regulatory requirements and allow us to quickly produce high-quality products.

  • Import independence

    The company creates solutions adapted to the Russian market, which ensures stable supplies and independence from external factors.

Our team

  • Suvorova Maria Alexandrovna

    CEO

  • Lyudyno Victoria Iosifovna

    Head of Research and Development Department

  • Mikulich Polina Anatolyevna

    Head of Production

  • Aksenova Svetlana Dzhonovna

    Head of Sales Department

  • Naumova Elena Evgenievna

    Head of Marketing

Our mission and values

We strive to make laboratory diagnostics more accurate and accessible by creating innovative solutions that help specialists deliver fast and reliable test results.
  • Science and innovation are at the heart of our business

    We apply science to everything from lab research to customer service, while remaining rational, curious and transparent.

  • Everything for the client and the patient

    We create only those solutions that bring real benefits to doctors and patients, without compromising on quality and efficiency.

  • We believe in the power of each person, we act together

    We are a team where everyone is valuable, and only through joint efforts can we create significant innovations for science, medicine and people.

  • Courage and responsibility

    We open new horizons in diagnostics, acting boldly, but always with an awareness of responsibility to society.

Our background

2012 – Alphalab was founded in St. Petersburg on the basis of the clinical research laboratory Explana. The company emerged as a response to the requests of medical specialists who needed more in-depth diagnostics of infections and parasitic diseases.

2013–2016 – active development of scientific research, launch of the first own PCR test systems and establishment of production.

2017–2020 – expansion of production capacity, strengthening of positions in the Russian market.

2021–2024 – entering the international level, development of new areas of diagnostics, implementation of advanced technologies in molecular biology and genetics.

Today, Alphalab is an advanced biotechnology company that develops and produces unique diagnostic solutions in demand by doctors and laboratories throughout Russia and beyond. We continue to grow rapidly, expanding our capabilities and creating products that change the approach to medical diagnostics.